image
Healthcare - Biotechnology - NASDAQ - US
$ 16.065
0.644 %
$ 1.05 B
Market Cap
-4.17
P/E
Price Target Average
161.44%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
25.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Mineralys Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for MLYS of $42 , with forecasts ranging from a low of $30 to a high of $48 .
MLYS Lowest Price Target Wall Street Target
30 USD 86.74%
MLYS Average Price Target Wall Street Target
42 USD 161.44%
MLYS Highest Price Target Wall Street Target
48 USD 198.79%
Price
Max Price Target
Min Price Target
Average Price Target
50504545404035353030252520201515101055Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart MLYS

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MLYS

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MLYS

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029